To access the efficacy of Amalkyadi Kaphaghna Basti with Lekhaghna Basti in the treatment of Dyslipidemia

Evaluation of Comparative efficacy of Amalkyadi Kaphghna basti versus Lekhana basti in the management of Dyslipedemia Medoroga A Randomized Controlled Clinical Trial

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062434

Enrollment

Registered

2024-02-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E66- Overweight and obesity

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are willing to give Written Informed Cosent Clinical cases of Dyslipidemia as per 1CD 10 Criteria E78 point 5 diagnosed with either sex between the age group of 20 to 50 years Diagnosed and confirmed cases of Dyslipidemia according to National Cholesterol Education Program and Adult Treatment Panel 3 NCEP ATPIII 2001 as follows Total cholesterol less than or equal to 200 mg per dL and or LDL from 130 to 189 mg per dL and or Sr Triglycerides between 150 to 499 mg per dL and or Sr HDL more than 40mg per dL

Exclusion criteria

Exclusion criteria: Patients who are not willing to give Written Informed Consent Patients with Unstable Angina myocardial infarction stroke transient ischemic attack cardiovascular surgery or major operations within 6 months prior to screening visit Patient having systemic illness like Tuberculosis Carcinoma Endocrine disorders and Renal or Liver disorder Drug induced Dyslipidemia like steroids etc Pregnant Lactating women Patients with Ano-rectal disorders like Fissure Fistula Haemorrhoids etc Patients with Hypothyroidism Patients with NIDDM Patients with Hypertension

Design outcomes

Primary

Measure	Time frame
To access the efficacy of Kaphaghna Basti in Lipid ProfileTimepoint: 1 month 15 days	—

Secondary

Measure	Time frame
To access the efficacy of Lekhana Basti in Lipid ProfileTimepoint: 45 Days;To access the efficacy of Tab Atrovastatin 10 mg in Lipid ProfileTimepoint: 45 Days	—

Countries

India

Contacts

Public ContactDr Punam Sawarkar

Datta Meghe Institute Of Medical Sciences

shamlihiware57@gmail.com7709793303

Outcome results